Enzalutamide for Biochemically Recurrent Prostate Cancer | NEJM

Описание к видео Enzalutamide for Biochemically Recurrent Prostate Cancer | NEJM

Patients frequently have biochemical recurrence after prostate cancer treatment. The hormonal therapy enzalutamide is under study as a potential treatment for these patients.

New research findings are summarized in a short video.

To see the full article, follow this link: https://nej.md/402Jenp

Комментарии

Информация по комментариям в разработке